CERo Therapeutics Holdings, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERO and other ETFs, options, and stocks.About CERO
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.
CEOChristopher B. Ehrlich
CEOChristopher B. Ehrlich
Employees—
Employees—
HeadquartersOakland, California
HeadquartersOakland, California
Founded2021
Founded2021
Employees—
Employees—
CERO Key Statistics
Market cap4.60M
Market cap4.60M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume686.63K
Average volume686.63K
High today$0.62
High today$0.62
Low today$0.5622
Low today$0.5622
Open price$0.5767
Open price$0.5767
Volume1.23M
Volume1.23M
52 Week high$110.00
52 Week high$110.00
52 Week low$0.5338
52 Week low$0.5338
People also own
Based on the portfolios of people who own CERO. This list is generated using Robinhood data, and it’s not a recommendation.